http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0211098-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c213ba9952360f439567152e047b18
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
filingDate 2002-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34da0a1f54d28055ffd0f1ebe9b29539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a09976dc0c0beb684768a900ec8a62e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca674b001560863c41dd938b1eda67f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b37c1d95e1756f889551d4ac7ee44892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cabe58dfd1b2af907f6fb647d6b766d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6f33a48f5443638c882a12da8339e2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63ed2e3556eb26d28e0deba0d53f7ad8
publicationDate 2004-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0211098-A
titleOfInvention Compounds and methods for trypanosoma cruzi inhibition
abstract "COMPOUNDS AND METHODS FOR INHIBITING TRYPANOSOMA CRUZI". The present invention relates to compounds according to formula (1): wherein RA is a substituted or unsubstituted branched chain or cyclic C1 -C10 alkyl or straight alkenyl group or a phenyl group according to formula (1). 11): RB is a substituted or unsubstituted branched chain or straight chain C1 -C10 alkyl or alkenyl group or a phenyl group according to formula (III): R1, R2, R3, R4, R5, R6, R 7, R 8, R 9 and R 10 are each independently selected from H, C 1 -C 10 (preferably a C 1 -C 4) alkyl or alkenyl group, CF 3, F, CI, Br, I, CN, NO 2, NH 2, NHR, NRR, COR (acyl group), OR (hydroxyl or ether group), CO2R (carboxylic acid or ester group), or COSR (thioester group), where R is H or a C1-C10 (preferably a C1-C4) alkyl or alkenyl group , an unsubstituted or substituted aryl (preferably phenyl) group or heterocycle group, or a group (IV), where R 3 is H, a C 1 -C 2 -C 10 (preferably a C 1 -C 4) alkyl group alkenyl, ether or thioester; and R 11 and R 12 are independently selected from H or a C 1 -C 3 alkyl or alkenyl group, or a pharmaceutically acceptable salt thereof and methods for treating infections caused by protozoal, fungal and / or bacterial agents such as Trypanosoma cruzi, Mycobacterium spp., Leishmania spp., Cryptococcus spp., Aspergillus spp., Histoplasma spp., Candida spp., Especially Candida albicans, Pneumocystis carinii, Trichophyton spp., Malassezia spp. Coccidiodes spp., Among others.
priorityDate 2001-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261

Total number of triples: 32.